Moderna Slump Hits 50% From Peak, Erasing $98 Billion Value

Moderna Inc. is on its longest losing streak in more than two years, extending its slump from a record high in August by 50%. 

The slide has wiped about $98 billion off the company’s market value since that peak. While the omicron variant is sweeping the world, Moderna’s shares were pressured as coronavirus pills by Pfizer Inc. and Merck & Co., Inc. recently received authorization from the FDA.

MSN Moderna Slump Hits 50% From Peak, Erasing $98 Billion Value